In our study, high expression of ANAPC7 was correlated with significantly worse RFS in the specific cohort of breast cancer patients, and the expression level of ANAPC7 was continuously high in the fulvestrant-resistant breast cancer cells. This evidence concerns the gene ANAPC7 and breast carcinoma.